Business
Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 23 August 2025
Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders. In tranche 2 of the private placement, including underwriting shares, 4,813, 857 total shares. Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, subscribed to 469,255 shares, ISIN NO0013536078, at NOK 3.30 per share, and Anders Storbråten, CEO
About this update from Idex Biometrics Asa
[{"type":"image","alt":"IDEX BIOMETRICS ASA","displaySize":"","headline":null,"caption":"IDEX BIOMETRICS ASA","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":99,"url":"https://media.zenfs.com/en/globenewswire.com/e9861ff864a1550fbbb308e020c27552"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/06iRU0u2vX7ltcONxES.qA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e9861ff864a1550fbbb308e020c27552","width":300,"height":99}},"lazy":false},{"type":"text","content":"Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders.","length":234,"tagName":"p"},{"type":"text","content":"In tranche 2 of the private placement, including underwriting shares, 4,813, 857 total shares.","length":94,"tagName":"p"},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, subscribed to 469,255 shares, ISIN NO0013536078, at NOK 3.30 per share, and Anders Storbråten, CEO and CFO, subscribed to 703,883 shares, ISIN NO0013536078, at NOK 3.30 per share.","length":255,"tagName":"p"},{"type":"text","content":"After the subscription by Pinchcliffe and Anders Storbråten, Mr. Storbråten and close relations hold 7,195,898 or 13,81% shares of the total outstanding shares and votes in IDEX Biometrics after completion of Tranche 2.","length":219,"tagName":"p"},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"K-konsult AS, a company closely related to chair Morten Opstad, subscribed to153,343 shares, ISIN NO0013536078, at NOK 3.30 per share, and Morten Opstad, chair, subscribed to 50,000 shares, ISIN NO0013536078, at NOK 3.30 per share.","length":231,"tagName":"p"},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"Contact personAnders Storbråten, CEO and CFO Tel: +47 4163 8582E-mail: [email protected]","length":95,"tagName":"p"},{"type":"text","content":"About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring co...